🌟 Breakthrough in Human Biology Research at Roche 🌟 Scientists from Roche #pRED and #TeamIHB have made an exciting discovery that could help to more accurately predict the effect of a drug. 💡 🎉 Check it out http://spkl.io/6042f6wc8 and share your thoughts with us! We can't wait to hear what you think! 💬
Info
Roche ist ein globales Unternehmen mit Vorreiterrolle in der Erforschung und Entwicklung von Medikamenten und Diagnostika und ist darauf fokussiert, Menschen durch wissenschaftlichen Fortschritt ein besseres, längeres Leben zu ermöglichen. Dank der Kombination von Pharma und Diagnostika unter einem Dach ist Roche führend in der personalisierten Medizin - einer Strategie mit dem Ziel, jeder Patientin und jedem Patienten die bestmögliche Behandlung zukommen zu lassen. Roche ist das grösste Biotech-Unternehmen weltweit mit differenzierten Medikamenten für die Onkologie, Immunologie, Infektionskrankheiten, Augenheilkunde und Erkrankungen des Zentralnervensystems. Roche ist auch der bedeutendste Anbieter von In-vitro-Diagnostika und gewebebasierten Krebstests und ein Pionier im Diabetesmanagement. Seit der Gründung im Jahr 1896 erforscht Roche bessere Wege, um Krankheiten zu verhindern, zu erkennen und zu behandeln und leistet einen nachhaltigen Beitrag zur gesellschaftlichen Entwicklung. Zum Ziel des Unternehmens gehört es durch Kooperationen mit allen relevanten Partnern den Zugang von Patienten zu medizinischen Innovationen zu verbessern. Auf der Liste der unentbehrlichen Arzneimittel der Weltgesundheitsorganisation stehen heute 30 von Roche entwickelte Medikamente, darunter lebensrettende Antibiotika, Malariamittel und Krebsmedikamente. Ausgezeichnet wurde Roche zudem bereits das neunte Jahr in Folge als das nachhaltigste Unternehmen innerhalb der Pharma-, Biotechnologie- und Life-Sciences-Branche im Dow Jones Sustainability Index. Die Roche-Gruppe mit Hauptsitz in Basel, Schweiz ist in über 100 Ländern tätig und beschäftigte 2017 weltweit rund 94 000 Mitarbeiterinnen und Mitarbeiter. Im Jahr 2017 investierte Roche CHF 10,4 Milliarden in Forschung und Entwicklung und erzielte einen Umsatz von CHF 53,3 Milliarden. Genentech in den USA gehört vollständig zur Roche-Gruppe. Roche ist Mehrheitsaktionär von Chugai Pharmaceutical, Japan. Weitere Informationen finden Sie unter www.roche.com/careers #Roche #Biotechnology #Pharmaceuticals #Diagnostics #Healthcare #PersonalizedHealthcare #GreatPlaceToWork #Innovation
- Website
-
http://www.roche.com/
Externer Link zu Roche
- Branche
- Biotechnologieforschung
- Größe
- 10.001+ Beschäftigte
- Hauptsitz
- Switzerland 🇨🇭
- Art
- Kapitalgesellschaft (AG, GmbH, UG etc.)
- Spezialgebiete
- biotechnology, innovation, personalized healthcare, great place to work, diagnostics, pharmaceuticals, research, healthcare, personalised healthcare, diabetes care, genomics, healthcare technology, big data und Science
Orte
Beschäftigte von Roche
Updates
-
🧬 Exciting things are happening at the intersection of AI and drug discovery! At TED AI, Aviv Regev, Genentech's Head of Research and Early Development, shared powerful insights into how artificial intelligence is revolutionizing the way we make medicines. When developing a new treatment solution, every step can be challenging, from identifying the right targets to developing the ideal treatments and predicting the best dosage for each patient. But when we blend cutting-edge science with advanced technology, we can accelerate the entire process, bringing life-saving treatments to patients faster and more efficiently. Curious to learn more? Watch Aviv’s full TED talk now! 🎥 🔗 http://spkl.io/6043f6Tph
-
-
Our mission: change lives 💡 Would you like to be part of a team that improves patients' lives every day? By continually advancing medical research and development, we are passionate about the lives of patients worldwide. With every project we take on and every challenge we overcome, our unwavering team spirit and innovative solutions drive us forward to shape a better future for everyone. 🚀 Read more about who we are and what we are standing for: https://lnkd.in/eP5pEfEY
-
-
This summer, Roche Continents 2024 in Arles, France, united students, scientists, and artists under the theme "Resourcefulness!". Together, we explored how collaboration in arts, science, and sustainability can address today's challenges. A few highlights: 🎤 Thought-provoking speeches from Roche leaders on the power of learning and innovation 💡 Creative workshops at LUMA Arles 🌱 Field activities at Tour du Valat focused on nature-based solutions 🗣️ Engaging tech talks on medical advancements 🖼️ An inspiring visit to the "Van Gogh and the Stars" exhibition At Roche, we believe in empowering young minds and fostering innovation to create a healthier future. Learn more: http://spkl.io/6048f6GjM #RocheContinents2024 #Innovation #Art #Science #Sustainability
-
-
Despite notable advancements in access and treatment options, few countries are on track to achieve the World Health Organization target of eliminating viral #hepatitis by 2030. Challenges such as lack of awareness, stigma and discrimination, limited funding, and political commitment, impede access to testing and care. In low and middle-income countries, liver diseases pose a significant public health challenge. The Asia-Pacific region alone makes up 63% of global liver disease deaths, with viral hepatitis and #livercancer cancer, predominantly HCC, being major contributors. Amidst high prevalence rates, limited access to healthcare services, and inadequate resources, are micro-elimination strategies the solution to improved liver patient care? Read this article http://spkl.io/6045f68Bd and share your thoughts in the comments below 👇
-
We're shining a light on a critical yet often overlooked challenge for the Spinal Muscular Atrophy (SMA) community: the transition from childhood to adulthood. Turning 18 can be a challenging time for anyone. But for those living with SMA, it’s a time that brings significant shifts in support systems, healthcare management, and personal independence. As advocates for those living with SMA, we're committed to highlighting the need to address these evolving needs, and ultimately ensure that individuals with SMA have access to the tools, resources and support networks necessary to thrive at every stage of life. Join us in this crucial conversation. Together, we can build a more supportive world for individuals with SMA as they navigate the journey into adulthood. Learn more here: http://spkl.io/60474hZNJ
-
We know how important recognition and appreciation are in professional life. 🌟 Your satisfaction and development are of great importance to us, which is why we offer flexible working hours and a wide range of opportunities for both professional and personal growth. 🎓🌿Our inspiring working environment is designed to ensure that you can fully develop and reach your highest potential. 🤝 Become part of our team and discover what it feels like to work in an appreciative and inspiring environment! Become part of Roche. https://lnkd.in/eSmS5D6z Click here and read more about our Benefits & Rewards: https://lnkd.in/ex5aT9Uj
-
-
🎙️ The latest episode of the SMA My Way podcast is live! 🌟 Join Martyn and Josh as they dig into the resilience and strength of individuals navigating the world of travel amid physical limitations, shedding light on the obstacles they have overcome. 🌍 ✈️ Discover how adversity within the travel industry can often lead to the most profound growth and unforgettable memories. Search “SMA My Way” in your preferred podcast streaming platform or click here to listen on Spotify 👉 http://spkl.io/60474hPex
-
🛣️ Your way - Be part of something bigger! Become part of a company that strives for success while prioritizing humanity and diversity 👥 Experience a dynamic community that values every voice and fosters a culture of collaboration and innovation. Join us, where your contributions make a real impact, and together we build a future that's inclusive and inspiring. Find more information about working at Roche: https://lnkd.in/eUU8W6M5
-
-
Despite significant progress in lung cancer diagnosis and treatment over the last 20 years, we still have a long way to go to ensure every person with lung cancer gets the care they need. Our teams are working tirelessly to expand our understanding of how lung cancer operates and discover potential new ways to tackle it. But this is just one piece of the puzzle - continued collaboration across the community is vital to making a difference for patients. On World Lung Cancer Day, we want to recognise and thank our partners in the lung cancer community as we continue to redefine lung cancer together to support people with lung cancer at every stage of their journey. Learn more: http://spkl.io/60454hJE3
Verbundene Seiten
Ähnliche Seiten
Finanzierung
Roche
Insgesamt 4 Finanzierungsrunden
![]()
SoftBank
Weitere Informationen auf Crunchbase
Letzte Runde
Kapitalerhöhung nach Börsengang
Externer Crunchbase-Link für die letzte Finanzierungsrunde
5.000.000.000,00 $
Investor:innen